In vivo effects of ascorbate and glutathione on the uptake of chromium, formation of chromium(V), chromium-DNA binding and 8-hydroxy-2'-deoxyguanosine in liver and kidney of Osteogenic Disorder Shionogi rats following treatment with chromium(VI)

Carcinogenesis

Volumn 20, Issue 7, 1999, Pages 1267-1275

  Yuann, Jeu Ming P ^a   Liu, Ke Jian ^b   Hamilton, Joshua W ^a,b   Wetterhahn, Karen E ^a  

^a Dartmouth College   (United States)

^b DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; ACETYLCYSTEINE; ASCORBIC ACID; BUTHIONINE SULFOXIMINE; CHROMIUM; DNA; GLUTATHIONE; PHORONE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; DNA ADDUCT; DNA BINDING; KIDNEY; LIVER; NONHUMAN; PRIORITY JOURNAL; RAT; REDUCTION;

ACETYLCYSTEINE; ANIMALS; ANTIMETABOLITES; ASCORBIC ACID; BUTHIONINE SULFOXIMINE; CHROMIUM; DEOXYGUANOSINE; DNA ADDUCTS; FREE RADICAL SCAVENGERS; GLUTATHIONE; KETONES; KIDNEY; LIVER; OXIDATION-REDUCTION; RATS; RATS, MUTANT STRAINS;

EID: 0032809361     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/20.7.1267     Document Type: Article

References (71)

1. IARC (1990) IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans: Chromium, Nickel and Welding. IARC, Lyon, pp. 1-214.
2. Leonard, A., Gerber, G.B., Jacquet, P. and Lauwerys, R.R. (1984) Carcinogenicity, mutagenicity, and teratogenicity of industrially used metals. In Kirsch-Volders, M. (ed.) Mutagenicity, Carcinogenicity, and Teratogenicity of Industrial Pollutants. Plenum Press, New York, NY, pp. 78-82.
3. Kazantzis, G. and Lilly, L.J. (1979) Mutagenic and carcinogenic effects of metals. In Friberg, L., Nordberg, G.F. and Vouk, V.B. (eds) Handbook on the Toxicity of Metals. Elsevier/North-Holland Biomedical Press, New York, NY, pp. 237-272.
4. Leonard, A. and Lauwreys, R.R. (1980) Carcinogenicity and mutagenicity of chromium. Mutat. Res., 76, 227-239.
5. Koster, A. and Beyersmann, D. (1985) Chromium binding by calf thymus nuclei and effects on chromatin. Toxicol. Environ. Chem., 10, 307-313.
6. Connett, P.H. and Wetterhahn, K.E. (1983) Metabolism of the carcinogen chromate by cellular constituents. Struct. Bonding, 54, 93-124.
7. Jennette, K.W. (1979) Chromate metabolism in liver microsomes. Biol. Trace Elem. Res., 1, 55-62.
8. Jennette, K.W. (1981) The role of metals in carcinogenesis: biochemistry and metabolism. Environ. Health Perspect., 40, 233-252.
9. Kawanishi, S., Inoue, S. and Sano, S. (1986) Mechanism of DNA cleavage induced by sodium chromate(VI) in the presence of hydrogen peroxide. J. Biol. Chem., 261, 5952-5958.
10. Shi, X., Dong, Z., Dalal, N.S. and Gannett, P.M. (1994) Chromate mediated free radical generation from cysteine, penicillamine, hydrogen peroxide and lipid hydroperoxides. Biochim. Biophys. Acta, 1226, 65-72.
11. Goodgame, D.M.L. and Joy, M. (1987) EPR study of the Cr(V) and radical species produced in the reduction of Cr(VI) by ascorbate. Inorg. Chim. Acta, 135, 115-118.
12. Stearns, D.M. and Wetterhahn, K.E. (1994) Reaction of chromium(VI) with ascorbate produces chromium(V), chromium(IV), and carbon-based radicals. Chem. Res. Toxicol., 7, 219-230.
13. Suzuki, Y. (1988) Reduction of hexavalent chromium by ascorbic acid in rat lung lavage fluid. Arch. Toxicol., 62, 116-122.
14. Norseth, T., Alexander, J., Aaseth, J. and Langard, S. (1982) Biliary excretion of chromium in the rat: a role of glutathione. Acta Pharmacol. Toxicol., 51, 450-455.
15. Suzuki, Y. and Fukuda, K. (1990) Reduction of hexavalent chromium by ascorbic acid and glutathione with special reference to the rat lung. Arch. Toxicol., 64, 169-176.
16. Standeven, A.M. and Wetterhahn, K.E. (1991) Ascorbate is the principal reductant of chromium(VI) in rat liver and kidney ultrafiltrates. Carcinogenesis, 12, 1733-1737.
17. Standeven, A.M. and Wetterhahn, K.E. (1992) Ascorbate is the principal reductant of chromium(VI) in rat lung ultrafiltrates and cytosols and mediates chromium-DNA binding in vitro. Carcinogenesis, 13, 1319-1324.
18. Xu, J., Bubley, G.J., Detrick, B., Blankenship, L.J. and Patierno, S.R. (1996) Chromium(VI) treatment of normal human lung cells results in guanine-specific DNA polymerase arrest, DNA-DNA cross-links and S-phase blockade of cell cycle. Carcinogenesis, 17, 1511-1517.
19. Standeven, A.M. (1991) The role of glutathione and ascorbate in the metabolism and toxicity of chromium(VI) in rats. Ph.D. thesis, Dartmouth College, Hanover, NH.
20. Borges, K.M., Boswell, J.S., Liebross, R.H. and Wetterhahn, K.E. (1991) Activation of chiomium(VI) by thiols results in chromium(V) formation, chromium binding to DNA and altered DNA conformation. Carcinogenesis, 12, 551-561.
21. Liebross, R.H. and Wetterhahn, K.E. (1992) In vivo formation of chromium(V) in chick embryo liver and red blood cells. Carcinogenesis, 13, 2113-2120.
22. Stearns, D.M., Kennedy, L.J., Courtney, K.D., Giangrande, P.H., Phieffer, L.S. and Wetterhahn, K.E. (1995) Reduction of chromium(VI) by ascorbate leads to chromium-DNA binding and DNA strand-breaks in vitro. Biochemistry, 34, 910-919.
23. Hamilton, J.W. and Wetterhahn, K.E. (1986) Chromium(VI)-induced DNA damage in chick embryo liver and blood cells in vivo. Carcinogenesis, 7, 2085-2088.
24. Liebross, R.H. and Welterhahn, K. E. (1990) In vivo formation of chromium(V) in chick embryo red blood cells. Chem. Res. Toxicol., 3, 401-403.
25. Liu, K.J., Jiang, J., Swartz, H.M. and Shi, X. (1994) Low-frequency EPR detection of chromium(V) formation by chromium(VI) reduction in whole live mice. Arch. Bicchem. Biophys., 313, 248-252.
26. Sugiyama, M., Tsuzuki, K. and Haramaki, N. (1993) Influence of o-phenanthroline on DNA single-strand breaks, alkali-labile sites, glutathione reductase, and formation of chromium(V) in Chinese hamster V-79 cells treated with sodium chromate(VI). Arch. Biochem. Biophys., 305, 261-266.
27. Sugiyama, M., Tsuzuki, K. and Haramaki, N. (1993) DNA single-strand breaks and cytotoxicity induced by sodium chromate(VI) in hydrogen peroxide-resistant cell lines. Mutat. Res., 299, 95-102.
28. Sugiyama, M., Tsuzuki, K. and Ogura, R. (1991) Effect of ascorbic acid on DNA damage, cytotoxicity, glutathione reductase, and formation of paramagnetic chromium in Chinese hamster V-79 cells treated with sodium chromate(VI). J. Biol. Chem., 266, 3383-3386.
29. Faux, S.P., Gao, M., Chipman, J.K. and Levy, L.S. (1992) Production of 8-hydroxydeoxyguanosine in isolated DNA by chromium(VI) and chromium(V). Carcinogenesis, 13, 1667-1669.
30. Shibutani, S., Takeshita, M. and Grollman, A.P. (1991) Insertion of specific bases during DNA synthesis past the oxidation-damaged base 8-oxo-dG. Nature, 349, 431-434.
31. Wood, M.L., Dizdaroglu, M., Gajewski, E. and Essigmann, J.M. (1990) Mechanistic studies of ionizing radiation and oxidative mutagenesis: genetic effects of a single 8-hydroxyguanine (7-hydro-8-oxoguanine) residue inserted at a unique site in a viral genome. Biochemistry, 29, 7024-7032.
32. Ames, B.N., Shigenaga, M.K. and Hagen, T.M. (1993) Oxidants, antioxidants, and the degenerative diseases of aging. Proc. Natl Acad. Sci. USA, 90, 7915-7922.
33. Kasai, H. and Nishimura, S. (1984) Hydroxylation of deoxyguanosine at the C-8 position by ascorbic acid and other reducing agents. Nucleic Acids Res., 12, 2137-2145.
34. Adachi, S., Zeisig, M. and Möller, L. (1995) Improvements in the analytical method for 8-hydroxydeoxyguanosine in nuclear DNA. Carcinogenesis, 16, 253-258.
35. Isherwood, F.A., Chen, Y.T. and Mapson, L.W. (1954) Synthesis of L-ascorbic acid in plants and animals. Biochem. J., 56, 1-15.
36. Chatterjee, I.B., Chatterjee, G.C., Ghosh, N.C., Ghosh, J.J. and Guha, B.C. (1960) Biological synthesis of L-ascorbic acid in animal tissue: conversion of L-gulonolactone into L-ascorbic acid. Biochem. J., 74, 193-203.
37. Horio, F., Ozaki, K., Yoshida, A., Makino, S. and Hayashi, Y. (1985) Requirement for ascorbic acid in a rat mutant unable to synthesize ascorbic acid. J. Nutr., 115, 1630-1640.
38. Mizushima, Y., Harauchi, T., Yoshizaki, T. and Makino, S. (1984) A rat mutant unable to synthesize vitamin C. Experientia, 40, 359-361.
39. Gandy, J., Bates, H.K., Conder, L.A. and Harbison, R.D. (1992) Effects of reproductive tract glutathione enhancement and depletion on ethyl methanesulfonate-induced dominant lethal mutations in Sprague-Dawley rats. Teratog. Carcinog. Mutagen., 12, 61-70.
40. 1 to DNA in the mouse. Toxicol. Appl. Pharmacol., 94, 118-127.
41. Standeven, A.M. and Wetterhahn, K.E. (1991) Possible role of glutathione in chromium(VI) metabolism and toxicity in rats. Pharmacol. Toxicol., 68, 469-476.
42. Berger, J., Shepard, D., Morrow, F. and Taylor, A. (1989) Relationship between dietary intake and tissue levels of reduced and total vitamin C in the nonscorbutic guinea pig. J. Nutr., 119, 734-740.
43. Lewin, S. (1976) Vitamin C, its Molecular Biology and Medical Potential. Academic Press, New York, NY.
44. Jernow, J., Blount, J., Oliveto, E., Perrotta, A., Rosen, P. and Toome, V. (1979) Structural determination of ascorbic acid 2-O-phosphate formed via acid hydrolysis of an ascorbic acid 3-O-phosphinate. Tetrahedron, 35, 1483-1486.
45. Bond, A., McClelland, B., Einstein, J. and Finamore, F. (1972) Ascorbic acid: 2-sulfate of the brine shrimp, Artemia salina. Arch. Biochem. Biophys., 153, 207-214.
46. Ellman, G.L. (1959) Tissue sulfhydryl groups. Arch. Biochem. Biophys., 82, 70-77.
47. Klotzsch, M. and Bergmeyer, H.-U. (1963) Methods of Enzymatic Analysis. Academic Press, New York, NY.
48. Riddles, P.W., Blakeley, R.L. and Zerner, B. (1979) Ellman's reagent, 5,5′-dithiobis(2-nitrobenzoic acid): a reexamination. Anal. Biochem., 94, 75-81.
49. Veillon, C. and Patterson, K.Y. (1986) Method 23 - determination of chromium in human tissues by atomic absorption spectrometry. In O'Neill, I.K., Schuller, P. and Fishbein, F. (eds) Environmental Carcinogens: Selected Methods of Analysis. Vol. 8. Some Metals. As, Be, Cr, Ni, Pb, Se, Zn. IARC, Lyon, pp. 433-439.
50. 8). J. Chem. Phys., 74, 1916-1923.
51. Yuann, J.-M.P. (1997) The roles of glutathione and ascorbate in chromium(VI)-induced Carcinogenesis, in vivo. Ph.D. thesis, Dartmouth College, Hanover, NH.
52. Venner, H. (1960) Synthesis of the 2′-deoxynucleosides of adenine, guanine, and hypoxanthine corresponding to the natural materials. Chem. Ber., 93, 140-149.
53. Tandon, S.K., Behari, J.R. and Kachru, D.N. (1979) Distribution of chromium in poisoned rats. Toxicology. 13, 29-34.
54. Iannone, A., Tomasi, A., Vannini, V. and Swartz, H.M. (1990) Metabolism of nitroxide spin labels in subcellular fractions of rat liver. II. Reduction in the cytosol. Biochim. Biophys. Acta, 1034, 290-293.
55. Shertzer, H.G., Vasiliou, V., Liu, R.-M., Tabor, M.W. and Nebert, D.W. (1995) Enzyme induction by L-buthionine (S,R)-sulfoximine in cultured mouse hepatoma cells. Chem. Res. Toxicol., 8, 431-436.
56. Frei, B., England, L. and Ames, B.N. (1989) Ascorbate is an outstanding antioxidant in human blood plasma. Proc. Natl Acad. Sci. USA, 86, 6377-6381.
57. Sinclair, P.R., Gorman, N., Sinclair, J.F., Walton, H., Bement, W.J. and Lambrecht, R.W. (1995) Ascorbic acid inhibits chemically induced uroporphyria in ascorbate-requiring rats. Hepatology, 22, 565-572.
58. Kortenkamp, A., Beyersmann, D. and O'Brien, P. (1987) Uptake of chromium(III) complexes by erythrocytes. Toxicol. Environ. Chem., 14, 23-32.
59. Edel, J. and Sabbioni, E. (1985) Pathways of Cr(III) and Cr(VI) in the rat after intratracheal administration. Hum. Toxicol., 4, 409-416.
60. Ueno, S., Susa, N., Furukawa, Y. and Sugiyama, M. (1995) Formation of paramagnetic chromium in liver of mice treated with dichromate(VI). Taxicol. Appl. Pharmacol., 135, 165-171.
61. Tsapakos, M. and Wetterhahn, K.E. (1983) The interactions of chromium with nucleic acids. Chem. Biol. Interact., 46, 265-277.
62. Sugden, K.D. and Wetterhahn, K.E. (1996) EPR evidence for chromium(V) binding to phosphate and pyrophosphate: implications for chromium(V)-DNA interactions. Inorg. Chem., 35, 3727-3728.
63. Sugiyama, M. and Tsuzuki, K. (1994) Effect of glutathione depletion on formation of paramagnetic chromium in Chinese hamster V-79 cells. FEBS Lett., 341, 273-276.
64. Hojo, Y. and Satomi, Y. (1991) In vivo nephrotoxicity induced in mice by chromium(VI): involvement of glutathione and chromium(V). Biol. Trace Elem. Res., 31, 21-31.
65. Salnikow, K., Zhitkovich, A. and Costa, M. (1992) Analysis of the binding sites of chromium to DNA and protein in vitro and in intact cells. Carcinogenesis, 13, 2341-2346.
66. Zhitkovich, A., Voitkun, V. and Costa, M. (1995) Glutathione and free amino acids form stable complexes with DNA following exposure of intact mammalian cells to chromate. Carcinogenesis, 16, 907-913.
67. 2 generation in perfused rat liver and the reaction of catalase compound I and hydrogen donors. Arch. Biochem. Biophys., 154, 117-131.
68. Maellaro, E., Del Bello, B., Sugherini, L., Santucci, A., Comporti, M. and Casini, A.F. (1994) Purification and characterization of glutathione-dependent dehydroascorbate reductase from rat liver. Biochem. J., 301, 471-476.
69. Paolicchi, A., Pezzini, A., Saviozzi, M., Piaggi, S., Andreuccetti, M., Chieli, E., Malvaldi, G. and Casini, A.F. (1996) Localization of a GSH-dependent dehydroascorbate reductase in rat tissues and subcellular fractions. Arch. Biochem. Biophys., 333, 489-495.
70. Winkler, B.S. (1992) Unequivocal evidence in support of the nonenzymatic redox coupling between glutathione/glutathione disulfide and ascorbic acid/dehydroascorbic acid. Biochim. Biophys. Acta, 1117, 287-290.
71. Kitagawa, S., Seki, H., Kametani, F. and Sakurai, H. (1988) EPR study on the interaction of hexavalent chromium with glutathione or cysteine: production of pentavalent chromium and its stability. Inorg. Chim. Acta, 152, 251-255.